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Highlights 
 
There is a decline in proteasome activity and levels of HSP70 with MRC-5 cell aging 
 
Cells utilise L-DOPA for L-tyrosine to generate  ‘oxidised’ aggregate-prone proteins 
 
Older MRC-5 cells degrade DOPA-containing proteins less efficiently than young 
cells  
 
HSP70 levels in older MRC-5 cells increases in response to DOPA and heat stress. 
 




Background: The accumulation of oxidised proteins in ageing cells and tissues results from an 
increase in oxidant damage coupled with impaired degradation of the damaged proteins. Heat 
Shock Proteins (HSP) and other chaperones are required to recognise damaged proteins and 
transport them to the lysosomal and proteasomal degradation pathways. How these systems 
fail in ageing cells is not clear. 
Methods: We monitor oxidised protein accumulation, the activity of the proteasome and 
lysosomal proteases, and HSP levels in MRC-5 fibroblasts throughout their mitotic lifespan. 
We then use a novel in vitro cell culture model to experimentally generate oxidised proteins 
in young and old MRC-5 fibroblasts and compare their rates of degradation and changes in 
the key pathways involved in oxidised protein removal.  
Results: We show that the activity of the proteasome and some lysosomal enzymes decreases 
with ageing in MRC-5 cells as do levels of HSP70 but this is not associated with an 
accumulation of oxidised proteins which only occurs as cells closely approach post-mitotic 
senescence. Old cells are unable to degrade experimentally generated oxidised proteins as 
efficiently as young cells. Exposure to mild heat stress however increases the efficiency of 
oxidised protein degradation by young cells and increases levels of HSP70. 
Conclusions: Our results highlight the importance of the HSP/chaperone system in oxidised 
protein metabolism, particularly in aging cells.  
General significance: These data might have implications for the development of therapies for 
pathologies associated with protein accumulation and suggest that the HSP/chaperone system 
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The accumulation of oxidised proteins and a gradual decline in proteasome [1-4] and 
lysosome function [5-8] are features of cellular aging. The accumulation of oxidised proteins 
results from an increase in oxidant damage coupled with the less efficient removal of the 
damaged proteins [9]. Removal by proteolysis is the primary defence against the 
accumulation of oxidised proteins [10]. Protein oxidation can result in protein unfolding 
which can expose previously buried hydrophobic regions and, if not rapidly recognised by 
heat shock proteins (HSPs), unfolded proteins can form aggregates through hydrophobic 
interactions [10]. Once this process is initiated, aggregates can grow and be stabilised by 
covalent cross-links, eventually rendering them protease-resistant. Failure of HSPs to rapidly 
recognise, bind to, and transport oxidised proteins to the degradation machinery can 
potentially result in protein aggregation and accumulation even when the proteolytic 
machinery is fully active. Since oxidised and aggregated proteins can directly inhibit the 
proteasome [11,12] and lysosomal cathepsins [13] it is difficult to determine to what extent 
loss of proteolytic activity in ageing is due to inhibition from accumulating oxidised and 
aggregated proteins. Impairment in the activity of the degradation pathways might not, by 
itself therefore, account for the extent of oxidised protein accumulation reported in aging. 
HSPs and other chaperones are required to recognise and target damaged proteins to both the 
lysosomal [14] and proteasomal pathways [15,16], failure of this quality control system to 
rapidly bind damaged proteins increases the likelihood of protein aggregation, cross-linking 
and resistance to proteolysis. Attenuated induction of HSP expression has been associated 
with fibroblast aging in vitro and with the age of primary cells obtained from donors [17,18]  
Naturally ageing human diploid fibroblast cells eventually reach their post-mitotic, 
Hayflick limit of replicative capacity and enter irreversible growth arrest or senescence. In the 
present studies we monitor oxidised protein levels in aging MRC-5 cells and correlate this 
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with changes in proteolytic activity and levels of HSPs. To generate ‘oxidised proteins’ in 
cells we use a model we have developed that allows cells to biosynthetically incorporate 
L-3,4-dihydroxyphenylalanine (DOPA) into proteins. DOPA is the primary oxidation product 
of hydroxyl radical attack on tyrosine residues and is present in proteins in tissues from 
age-related diseases such as atherosclerosis [19] and cataractogenesis [20]. We have 
previously demonstrated that DOPA can be mistakenly incorporated into cell proteins during 
protein synthesis and replaces the protein amino acid L-tyrosine [21,22]. Incorporation of 
DOPA into proteins can lead to protein misfolding and exposure of previously buried 
hydrophobic regions resulting in loss of solubility [23]. DOPA is also a potent cross-linker 
and can form cross-links with histidine residues [24] and cysteine residues [25]. This provides 
a useful in vitro model to study protein misfolding and aggregation. We use this model system 
to examine the effects of DOPA-containing proteins, on the protein degradation pathways in 
young and old fibroblasts. We investigate how HSP levels change with ageing and 
demonstrate that mild heat stress can reduce the accumulation of oxidised proteins in this 
model.  
 
2. Material and methods 
2.1 Reagents 
 
EMEM (Eagle’s Minimal Essential Medium) deficient in tyrosine, phenylalanine and Phenol 
Red was from JRH Biosciences. L-[3-14 C-alanine] dopa and L-[U-14 C] leucine were !from 
Amersham Biosciences (GE Healthcare). N-succinyl-Leu-Leu-Val-Tyr-AMC (where Suc is 
succinyl and AMC is 7-amino-4-methylcoumarin) and Boc-Leu-Ser-Thr-Arg-AMC (where 
Boc is t-butoxycarbonyl) were purchased from Sigma Chemical Co. Z-Arg-Arg-AMC (where 
 6 
Z is benzyloxycarbonyl), Z-Phe-Arg-AMC and Ac-Nle-Pro-Nle-Asp-AMC (where Ac is 
acetyl and Nle is norleucine) were from Bachem AG. Anti-Hsp70 (cat # 386013) and 
anti-Hsp27 rabbit polyclonal (cat # 386035) were purchased from Calbiochem, Darmstadt, 
Germany. Anti-Hsp90 rabbit polyclonal (cat# ab53110) and HRP-conjugated anti-rabbit IgG 
H&L goat polyclonal secondary antibody (cat# ab6721) was purchased from Abcam Inc, 
Cambridge, UK.  
All aqueous solutions and buffers were prepared using water filtered through a 
four-stage Milli-Q system (Millipore). All other chemicals, solvents and chromatographic 
materials were of analytical reagent or cell-culture grade. 
 
2.2 Cell culture 
 
MRC-5 cells, a human lung fibroblast cell line (ATCC® number, CCL-171) were cultured in 
EMEM supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS), 100 U/mL 
penicillin and 0.1 mg/mL streptomycin (concentrated premix; Cambrex Bio Science; MD, 
USA) and 2 mM L-glutamine. Cells were maintained at 37°C with 5% CO2.  
For studies involving the synthesis of DOPA-containing proteins, cells were cultured in 
tyrosine-deficient EMEM supplemented with a range of concentrations (50–750 µM) of 
L-DOPA over 4–24 hours. As negative controls, cells were incubated in tyrosine- deficient 
EMEM. Medium also contained 10% heat-inactivated FBS, 100 U/mL penicillin and 0.1 
mg/mL streptomycin (premixed) and 2 mM L-glutamate.. After incubations, medium was 
removed and the MRC-5 cells harvested by trypsin-EDTA. Cell pellets were then collected by 
centrifugation at 2,500 rpm for 5 min, washed twice with phosphate buffered saline (PBS) and 
stored at -80  ̊C until required. The extent of DOPA incorporation into cellular proteins is 
expressed as a ratio mole per mole of tyrosine. 
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The cells subjected to mild heat stress were placed at 45°C for 15 minutes in atmospheric CO2 
prior to treatment with DOPA. 
 
2.3 HPLC analysis 
 
Cell were washed and lysed by three freeze thaw cycles. Proteins were isolated by 
precipitation in TCA (5%), delipidated and washed by resuspending twice in 5% TCA 
containing 0.02% sodium deoxycholate and 0.15 mg/mL sodium borohydride (reducing 
agent) then washed twice with ice-cold acetone. The protein pellets were hydrolysed under 
anaerobic conditions (HCl and β-mercaptoacetic acid) using a standard gas-phase 
acid-catalysed method [26]. The level of DOPA in protein was determined by reverse-phase 
HPLC, using a LC-10A system from Shimadzu Co. (Kyoto, Japan) equipped with a 
CTO-10ASvp column oven (Millipore Co.) set at 30°C and methods described previously 
[19,21]. System operation was automated by Class LC-10 software. Chomatography was 
performed on a Zorbax ODS column with an attached Pelliguard guard column (LC-18). The 
elution was performed using a binary gradient of Buffer A (100 mM sodium perchlorate and 
10 mM sodium phosphate buffer, pH 2.5) and Buffer B (80% (v/v) methanol) at a flow rate of 
1 mL/min as follows: isocratic elution with 4% Buffer B for 25 min, 10% Buffer B for 5 min, 
increase to 40% Buffer B and maintained 40% Buffer B for 20 min, re-equilibration at 1% 
Buffer B for the final 10 min. UV λ280 nm (Shimadzu Co.), fluorescence (λex280nm and λem 
320nm, Hitachi F-1080, Tokyo, Japan) and electrochemical detector (ECD; Antec Leyden 
BV, Zoeterwoude, Netherlands) with the electrode potential set at 1.2 V measurements of the 
eluent were monitored in series. The amount of oxidised derivative incorporated into proteins 
was quantified from standards used, calculated as a ratio of mol oxidised derivative to mol of 
parent amino acid tyrosine.  
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2.4 Activity studies 
 
All assays were carried out in 96-well plates in triplicates and no protein control was included. 
Change in fluorescent or colourimetric unit/min/protein (g) was calculated and expressed as a 
percentage (%) of control values. The protein concentration was determined using the 
Bradford-based total protein assay. 
 
2.5 Measurement of proteasome activity  
 
Proteasome chymotryptic, peptidylglutamyl-peptide-hydrolysing (PGPH) and tryptic 
activities were measured by the initial linear rates of cleavage of the fluorescent reporter 
group (7-amino-4-methylcoumarin/AMC) from peptide substrates 
N-Succinyl-Leu-Leu-Val-Tyr-AMC (Sigma-Aldrich Co., MO, USA), 
Acetyl-Nle-Pro-N[27]le-Asp-AMC (where Nle is norleucine; Bachem Holding AG, 
Bubendorf, Switzerland), Boc-Leu-Ser-Thr-Arg-AMC (where Boc is t-butoxycarbonyl; 
Sigma-Aldrich Co.) respectively (previously described in [22,27]. Pelleted cells were 
resuspended in homogenising buffer containing 250 mM sucrose, 5 mM MgCl2, 2 mM ATP, 
1 mM DTT, 0.025% digitonin, 0.5 mM EDTA and 50 mM Tris-HCl, pH 7.5 at 4°C. This 
homogenate was incubated on ice for 5 min to allow digitonin-mediated permeabilisation of 
the cell membrane followed by centrifugation at 20,000 x g for 15 min at 4°C. Samples were 
incubated for 30 min at room temperature in the presence or absence of the proteasome 
inhibitor epoxomicin (20 µM). Proteasome activity was measured in reaction buffer (0.05 
mg/mL BSA, 40 mM KCl, 5 mM MgCl2, 0.5 mM ATP, 1 mM DTT and 50 mM Tris-HCl, 
pH7.5) with 100 µM chymotryptic/PGPH or 600 µM for the tryptic substrates by measuring 
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the change in fluorescence (λex360 nm and λem469 nm) for 30 min.  
 
2.6 Measurement of cathepsin L, B and S activities 
 
Cathepsin L, B and S activity were measured by the initial linear increase in fluorescence 
following the cleavage of AMC from peptide substrates Z-Phe-Arg-AMC (where Z is 
benzyloxycarbonyl), Z-Arg-Arg-AMC and Z-Val-Val-Arg-AMC (all from Bachem Holding 
AG) respectively [22]. For cathepsins L and B, 1/21 of final volume of cell lysate and reaction 
buffer (2.5 mM DTT, 5 mM EDTA, 1 µM pepstatin A, 5 mM benzamidine, 0.1 M phosphate 
buffer pH 6 (cathepsin B) or pH 5.5 (cathepsin L) containing 0.005% Brij 35) were incubated 
for 5 min at room temperature on a shaker. 200 µM cathepsin B or L substrate was added to a 
final volume of 210 µL per assay and the fluorescence was measured (λex360 nm and λem469 
nm) for 30 min. For cathepsin S, different reaction buffer was used (5 mM benzamidine, 5 
mM EDTA, 1 µM pepstatin A, 0.01% Triton X-100, 1 mM PMSF, 5 mM DTT and 0.2 M 
phosphate buffer, pH 7.5) and was incubated for 60 min at 40°C and the fluorescence was 
measured for 50 min.  
 
2.7 Measurement of arylsulphatase activity 
 
Arylsulphatase activity was measured by hydrolysis of the ester sulphate bond of the 
fluorogenic substrate, p-nitrocatecholsulphate [28]. 19x volume of reaction buffer (0.1% 
Triton X-100, 7.5 mM p-nitrocatecholsulphate and 0.1 M sodium acetate buffer, pH 5.0) was 
added to cell lysate and incubated at 37°C for 30 min. The reaction was terminated with the 
addition of an equal amount of stop buffer (4.76 mM HCl containing 0.19% (w/v) 
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hydroquinone freshly mixed 1:1 with 2.38 M NaOH containing 4.76% Na2SO3). Absorbance 
was measured at λ540 nm. 
 
2.8 Measurement of acid phosphatase activity 
 
Acid phosphatase activity was measured in cell lysates by hydrolysis of the phosphate group 
from the fluorogenic substrate, p-nitrophenyl phosphate. 4x volume of reaction buffer (8 mM 
p-nitrophenyl phosphate, 90 mM sodium acetate-acetic acid, pH 5.0) was added to each well 
then the plate incubated at 37°C for 30 min. The reaction was terminated by the addition of 
NaOH stop buffer to a final concentration of 176 mM NaOH. Absorbance was measured at 
λ410 nm.  
  
2.9 Measurement of lysosomal acid lipase activity 
 
Lysosomal acid lipase activity was estimated in the cell lysates by hydrolysis of the 
fluorogenic substrate, 4-methylumbelliferyl-oleate [29]. Initially, 4-methylumbelliferyl-oleate 
is resuspended in hexane (100 mg/mL) and then diluted 1 in 100 in 4% Triton X-100. 2x the 
volume of 4-methylumbelliferyl-oleate stock and 5x volume of assay buffer (0.2 M sodium 
acetate and 0.001% Tween 20, pH 5.5) were added to samples and incubated at 37°C for 30 
min; the reaction was stopped by adding a half volume of 0.75 M Tris, pH 8.0. Fluorescence 
measurements were measured with λex360 nm and λem469 nm. 
 
2.10 Degradation studies 
 
The rate of degradation of bulk proteins containing L-[U-14C]leucine (14C-leucine) or 
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L-3,4-dihydrophenyl[3-14C]alanine (14C-DOPA), synthesised in the presence of DOPA was 
measured. The specific activities of 14C-leucine and 14C-DOPA were 51.0 mCi/mmol and 306 
mCi/mmol respectively, and the radioactive concentrations were 51.0 µCi/mmol and 250 
µCi/mmol, respectively. Both radioactive labels were purchased from GE Healthcare. The cell 
culture method used to generate DOPA-containing proteins was as described previously [21]. 
Cells maintained in tyrosine- and leucine-free EMEM were incubated in the presence 
of 0.25 µM 14C-leucine and varying concentrations of DOPA (0, 250, 500, 750 µM) for 24 h. 
After 24 h of incubation, the medium was replaced with ‘chase’ medium; EMEM saturated 
with 10 µM leucine and 10 µM tyrosine, and cells were maintained in culture for a further 8 h 
to allow degradation of the labelled proteins. In experiments using 14C-DOPA, tyrosine-free 
EMEM contained 5 µM 14C-DOPA (with the balance of unlabelled DOPA) and EMEM 
saturated with 10 µM tyrosine was used as the ‘chase’ medium. Cells were harvested and the 
radioactivity in the culture medium and cell lysate measured by liquid scintillation counting. 
Bulk (14C-leucine-labelled) and 14C-DOPA-containing protein degradation was measured 
from the release of free radioactivity into the culture medium. Degradation was expressed as a 
percentage of the free radioactivity counts in medium to the total number of counts in the 
system (ie the total pool of labelled proteins at the start of the degradation period). 
 
2.11 Fluorescence microscopy 
 
Cellular autofluorescence was imaged using an Olympus IX71 Inverted Research 
Fluorescence Microscope (Olympus Co., Tokyo, Japan) equipped with an NIBA filter unit 
(λex470–490 nm, λem515–550 nm). Cells were exposed for 0.22 s. and images captured using 
the DP Controller software version 3.1.1.267 (Olympus Co.). 
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2.12 Western blotting 
 
The SDS-polyacrylamide gel electrophoresis method described here was modified from the 
manufacturer’s instructions for NuPAGE® Novex Bis-Tris gels (Invitrogen Co.). Cell pellets 
were lysed using the a Mammalian Cell Lysis kit (Sigma-Aldrich). Cell lysates were mixed 
with 4x NuPAGE® LDS sample buffer and 10x NuPAGE® reducing agent, denatured at 
100°C for 5 min and immediately cooled on ice for 2 min. Samples containing up to 20 µg of 
protein were loaded per lane alongside 10 µL SeeBlue Plus 2 Pre-Stained molecular weight 
markers (4–250 kDa) onto a 10-well NuPAGE® Bis-Tris 4–12% pre-cast gel, 1.5 mm thick. 
The proteins were separated under denaturing conditions in NuPAGE® MES SDS Running 
Buffer, pH 6.4 with an addition of 500 µL NuPAGE® antioxidant to maintain reducing 
conditions. The electrophoresis was run at 100 V for 5 min, 150 V for 5 min followed by 200 
V for 30 min for MES using the XCell SureLockTM Mini-Cell system (Invtirogen Co.). 
After SDS-PAGE separation, proteins were transferred onto nitrocellulose membranes, using 
the iBlotTM dry blotting system (Invitrogen Co.) and iBlotTM transfer stacks over 7 min using 
built-in ‘P2’ transfer program. Nitrocellulose membranes were blocked by incubating in 5% 
skim milk in Tris-buffered saline (10 mM Tris-HCl, pH 7.4, 150 mM NaCl) overnight at 4°C 
and incubated with the primary antibody diluted in 0.1% TBS-T (10 mM Tris-HCl, pH 7.4, 
150 mM NaCl and 0.1% Tween 20) for 1 h at room temperature: rabbit polyclonal 
anti-HSP27 (Calbiochem #386013) was used at 1:10,000, rabbit polyclonal anti-HSP70 
(Calbiochem #386035) was used as 1:50,000 and rabbit polyclonal anti-HSP90 (Abcam Inc. 
#ab53110) was used as 1:1,000. 
Membranes were washed and incubated in secondary antibody conjugated to HRP 
diluted in 0.1% TBS-T for 1 h at room temperature on a rotating platform. HRP-conjugated 
anti-rabbit IgG H&L goat polyclonal secondary antibody from Abcam Inc. (cat. no. #ab6721) 
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at 1:10,000 and the membrane was incubated in HRP-ECL Western Blotting detecting 
solution as per manufacture’s instructions (GE Healthcare) at room temperature for a 
maximum of 5 min. The detection reagent was removed and the membrane was exposed 
under chemiluminescence on the ChemiDoc XRS system (Bio-Rad Laboratories, Inc.). The 
relative expression of target protein was analysed using the densitometry function of 
QuantityOneTM software version 4.6.  
 
2.13 Statistical Analysis 
 
All results presented here as mean plus or minus standard error of the mean ( ±SEM). 
Statistical analyses were evaluated using GraphPad software (CA, USA) Prism 4 version 4.03 
either using a one-way or a two-way ANOVA with Bonferroni multiple comparison post-tests 
to compare replicate means between different treatments across the samples. Differences were 




3.1 DOPA-containing proteins accumulate with in vitro cellular aging.  
 
MRC-5 fibroblasts are capable of 42 to 46 population doublings before the onset of 
post-mitotic senescence. MRC-5 cells were initiated in culture at population doubling (PD) 10 
and maintained until senescence was reached (approximately 6 months in culture). Cells were 
sampled at various PD times (203 separate lysates) and protein-bound DOPA quantitated as a 
measure of oxidative damage to proteins. DOPA was released from the protein chain by acid 
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hydrolysis [19] and levels quantitated using HPLC. DOPA levels (µmol DOPA per mol 
tyrosine) remained constant until cells entered the final phases of their mitotic life and a steep 
increase in DOPA levels in proteins was evident (Figure 1A: PD38: P < 0.001). This linear 
increase continued until cells entered post-mitotic senescence and did not undergo further 
division (PD42; P < 0.001, Figure 1A).  
Post-mitotic cells were then maintained in culture for 3 months after becoming senescent. 
When viewed with microscopy, intense perinuclear fluorescence was present, consistent with 
the presence of protein aggregates (Figure 1B). This was not seen in young (PD16) or aging 
(PD36) cells (data not shown).  
 
3.2 Changes in HSP levels and proteasomal and lysosomal activity with aging.  
 
There was an overall attenuation of proteasomal catalytic activities in aging cells (PD36) 
when compared to young cells (PD16). The tryptic activity was the most significantly affected, 
falling to 43% (P = 0.0360), followed by the PGPH activity which was 66% (P = 0.0022) of 
that in young cells (Table 1). There was a trend towards reduced activity at the chymotryptic 
site (10% reduction in aging cells) but this did not reach significance (Table 1). Lysosomal 
protease and non-protease activities were also attenuated, reflecting a general decline in 
lysosomal function (to ~70%) in aging cells (Table 1).   
Heat shock proteins have also been reported to decline with age, and we used western blotting 
to quantitate the levels of HSP27, HSP70 and HSP90 in cell lysates. Levels of HSP27 and 
HSP90 protein did not change with aging in MRC-5 fibroblasts (Figure 2B and C), however 
HSP70 protein levels were significantly (P < 0.001) decreased (Figure 2A).  
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3.3 Generating DOPA-containing proteins in cells: a model for oxidized protein 
accumulation 
 
We experimentally generated DOPA-containing proteins in young (PD16) and aging (PD36) 
cells using a novel model developed in our laboratory [16,25]. In tyrosine-free medium the 
young rapidly dividing cells readily incorporated DOPA into newly synthesised proteins 
(Figure 3A) and even at 50 µM DOPA around 23% of tyrosine residues had been replaced 
with DOPA (Figure 3A). In older cells the rate of cell division and protein synthesis are much 
slower and the level of DOPA incorporation increased with increasing supply of DOPA in the 
medium (Figure 3A) and at 750µM DOPA around 9% of tyrosine residues had been replaced 
with DOPA (Figure 3A).  
 
3.4 Biosynthetically generated DOPA-containing proteins did not decrease cell viability 
 
To ensure the presence of DOPA-containing proteins did not adversely affect cell viability, 
we conducted LDH assays on young and aging cells. There was no increase in LDH release 
after 24 hours by young or aging cells when incubated with 750 µM DOPA or below (Figure 
3B).  
 
3.5 Turnover of bulk proteins and DOPA-containing proteins in young and ageing cells  
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To determine the effects of aging on the turnover of normal and DOPA-containing proteins, 
young (PD16) and aging (PD36) cells were incubated with increasing concentrations of 
DOPA, and the degradation of bulk cell proteins (14C-leucine-labeled) and 
‘oxidized/damaged’ proteins (14C-DOPA-labeled proteins) measured. After a 24 hr protein 
labeling period, cells were subjected to a “chase period” consisting of an 8 hour incubation in 
medium containing tyrosine and lysine (25 mM) to allow the degradation of labelled proteins. 
Release of the radiolabeled amino acid was quantitated as described previously [25].  
The degradation of bulk proteins (labeled with 14C-leucine) by aging cells (PD36) was 
significantly impaired at the highest concentration of DOPA (750 µM), when compared to 
young cells (PD16) (Figure 4A). This suggests that the aging cells were unable to maintain 
basal protein degradation rates when DOPA-containing proteins were present at higher levels. 
We then selectively examined the turnover of oxidised proteins, (labeled with 14C-DOPA) 
over the 8 hour chase period. The rate of removal of DOPA-containing proteins was 
significantly faster (~4 times) than bulk proteins (Figure 4B). Indicating that the proteolytic 
machinery of the cell specifically recognised DOPA-containing proteins as substrates for 
degradation. The rate of turnover of DOPA-containing proteins in aging cells however 
declined with increasing concentrations of DOPA to a greater extent than in young cells 
which were only able to maintain the higher level of turnover at concentrations up to 500 µM 
DOPA (Figure 4B).  
 
3.6 DOPA-containing proteins restored HSP70 levels in ageing cells 
  
In ageing cells levels of HSP70 protein had significantly declined by PD30 (Figure 2A). 
Treatment of PD36 cells with DOPA (500µg for 24 hours) had no effect on HSP levels in 
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young cells but selectively increased HSP70 levels in old cells effectively restored it to the 
level present in young cells (Figure 5).  
 
3.7 Mild heat stress improves the rate of turnover of DOPA-containing proteins 
 
We exposed old cells to mild heat stress by incubating them at 45°C for 15 min immediately 
prior to incubation with DOPA (0 – 24 hrs). We then compared the turnover of 
DOPA-containing proteins in aging cells that had been subjected to mild heat stress to control 
cells (without mild heat stress) and found there was a significant increase in the rate of 
degradation of DOPA-containing proteins at 750 µM in the heat stressed cells (Figure 6B).  
There was a marked increase in the expression of HSP70 by western blot after exposure to 
mild heat stress (Figure 6A) demonstrating that this was one factor that contributed to their 






One of the most commonly observed changes in aging is the accumulation of damaged and 
aggregated material (lipofuscin/age-pigments) in cells, a large proportion of which is oxidised 
protein. The primary pathway for removal of oxidised proteins is degradation to their 
constituent amino acids, but this process appears to be impaired with aging and in some 
age-related diseases [30]. In the present studies we used an in vitro model system to examine 
the factors contributing to the decreased ability of ageing MRC-5 fibroblasts to degrade 
experimentally generated oxidised and aggregate-prone proteins.  
Using protein-bound DOPA as a marker of oxidative damage to proteins, we monitored 
oxidised protein accumulation throughout the lifespan of MRC-5 cells. There was no increase 
in DOPA-containing proteins throughout most of the ageing process but a rapid increase in 
DOPA was evident in proteins when cells reached PD36 and the rate of cell division was 
greatly reduced. This is consistent with the idea that the distribution of oxidised proteins 
amongst daughter cells is an important mechanism for reducing oxidised protein 
accumulation in dividing cells. DOPA levels increased further as the cells entered 
post-mitotic senescence (PD42) (Figure 1A). The accumulation of DOPA-containing proteins 
corresponded to a decline in the activity of the proteasome and some lysosomal enzymes 
(Table 1) and a decline in levels of HSP70. Even although a significant decline in HSP70 
protein levels were observed at PD32, levels of HSP27 and HSP90 were maintained even 
after senescence was reached suggesting that certain HSPs selectively decline with cellular 
aging.  
We then generated DOPA-containing proteins in cells as a model of oxidised proteins. DOPA 
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is known to be the primary oxidation product of tyrosine residues in proteins and is present in 
proteins in ageing [20] and disease [19]. This approach has advantages over conventional 
methods of generating oxidised proteins since the use of strong oxidants such as paraquat [26] 
or hydrogen peroxide [27] can cause extensive damage to other biological molecules such as 
lipids and DNA [1,17]. Using the incorporation approach we can generate a precise pool of 
proteins containing oxidised amino acids without damage to other molecules and can thereby 
preserve cell viability. To do this we supplied DOPA to the cells in tyrosine-free medium so 
that DOPA could more effectively compete with tyrosine (present in the cell and in the foetal 
calf serum) for charging by tyrosyl tRNA synthetase and insertion into the polypeptide chain 
of proteins [16,25]. The presence of DOPA and DOPA-containing proteins had no effect on 
cell viability at the levels we used (Figure 3B). Incorporation of DOPA into proteins results in 
the generation of non-native/oxidised proteins in cells and thus might equate to a period of 
acute oxidative stress or an inflammatory insult in vivo. When DOPA-containing proteins 
were present in cells, both young and aging cells degraded these proteins much more rapidly 
than native (14C leucine labeled) proteins (Figure 4A & B) proving evidence that the cells 
recognise at least some of the DOPA-containing proteins as damaged and selectively 
degraded them. We have previously demonstrated that degradation of DOPA-containing 
proteins by cells is biphasic, and at higher levels of DOPA incorporation, DOPA-containing 
proteins resist degradation [16] and aggregate [6]. In the present studies, at higher DOPA 
concentrations, there was a significant decline in the rate of degradation of DOPA-containing 
proteins in aging cells relative to young cells (Figure 4B). The ability of aging cells to 
degrade aggregate-prone, DOPA-containing proteins was clearly impaired. The two major 
pathways for the degradation of oxidized proteins are the proteasome and lysosomes. We 
showed that there was a reduction in the activity of the proteasome in aging cells compared to 
young cells where the trypsin-like activity was reduced to 43%, the PGPH to 66% and the 
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chymotrypsin to 89% (Table 1). The observation of an age-related reduction in proteolytic 
activity is supported by a large body of evidence [2,30] and this also applies in age-related 
pathologies [31–35]. A reduction in proteasome activity in aging cells also corresponded to a 
decline in the activity of the lysosomal enzymes; aryl sulphatase, acid phosphatase and acid 
lipase (Table 1). This may have been a result of an overall reduction in the population of 
lysosomes in the ageing cells.  
There was a significant reduction in HSP70 protein levels in aging MRC-5 cells before there 
was any evidence of oxidised protein accumulation (Figure 2A). HSP70 is an inducible 
cytosolic heat shock protein that rapidly responds to thermal or oxidative stress, to sequester 
misfolded proteins by its binding domain, and thus preventing damaged proteins from 
forming aggregates. In this study we showed that HSP70 could be induced in aging cells both 
by exposure to DOPA or mild heat stress (Figures 5 and 6). Exposure to mild heat stress 
resulted in a small but significant increase in the rate of degradation of DOPA-containing 
proteins suggesting that HSP70 played a role in facilitating the degradation of these proteins 
(Figure 6B). 
The accumulation of oxidised proteins in cells and tissues is a common feature of 
neurodegeneration and other disorders associated with aging. As was evident in the present 
studies, cell division and the distribution of oxidised material amongst daughter cells is an 
important mechanism that allows dividing cells to limit the accumulation of oxidised proteins 
[36,37]. The inability of senescent cells to divide could therefore account for the rapid 
accumulation of DOPA-containing proteins. This could occur in long-lived cells such as 
retinal pigment epithelial cells or neurons. Age pigments have also been shown to directly 
inhibit the function of the proteasomes and the lysosomes leading to a decline in cell function.  
Whilst a great deal of research has focused on changes to the proteolytic machinery in aging 
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and neurodegeneration HSPs, which serve a critical upstream function, have received less 
attention. HSPs serve several roles in maintaining homeostasis including, protecting against 
aggregation, solubilizing of early stage protein aggregates, assisting in folding of nascent 
proteins or in refolding of damaged proteins. Importantly they also target damaged proteins to 
the degradation machinery and sequester non-degradable proteins to larger aggregates [12].  
 
Conclusions 
By experimentally generating oxidised proteins in cells we showed that the basal turnover of 
cell proteins was maintained in ageing MRC-5 cells and they were able to efficiently degrade 
low levels of oxidised proteins. When higher levels of oxidised proteins were experimentally 
generated however their degradation in ageing cells was less efficient than in young cells. 
Impairment in proteasome activity and a decline in HSP function appeared to contribute to the 
decline in oxidised protein turnover. HSP70 levels were reduced in ageing cells but could be 
increased by mild heat stress resulting in an increased ability to degrade oxidise proteins. 
These studies describe a useful in vitro model to study the mechanisms of degradation of 
damaged or non-native proteins and highlight the importance of heat shock proteins in the 
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Legends to Figures 
 
Table 1: The peptidase activity of the proteasome (chymotrypsin-like, trypsin-like and PGPH 
activities), the lysosomal proteases (cathepsins B, L and S) and activity of lysosomal 
arylsulphatase, acid phosphatase and acid lipase in aging (PD36) MRC-5 cells and young 
(PD16) cells was compared. Activity was measured using fluorescently labelled substrates 
and set at 100% for young cells. Results represent triplicate sets of cultures and data was 
expressed as change in fluorescence per minute per mg of protein. * p < 0.05, **p < 0.01, 
errors represent SEM.  
 
Figure 1: A. Accumulation of protein-bound DOPA in ageing MRC-5 fibroblasts. DOPA in 
hydrolysed cell proteins was measured by HPLC and expressed as a ratio to tyrosine. B. At 
PD42 MRC-5 cells entered post-mitotic senescence. Cells were maintained in culture for 
more than 3 months after reaching post-mitotic senescence and native autofluorescence 
imaged using an inverted Olympus IX71 microscope with a NIBA filter set (ex 470–490nm, 
em 515–550nm) equipped with a DP71 digital camera with exposure of 0.22 seconds.  
 
Figure 2: Densitometric analysis of HSP levels in MRC-5 cell lysates identified by western 
blotting. Cells were examined between PD13 and PD40 for levels of: A. HSP70, B. HSP90 
and C. HSP27. Relative expression was quantified by densitometry (see insets). Statistically 
significant changes in the HSP protein levels relative to the young cells (PD16) were as 
indicated, ** p < 0.01, ***p < 0.001 and errors represent SEM. 
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Figure 3: A. Incorporation of DOPA into cell proteins from young (PD16) and aging (PD36) 
MRC-5 cells was measured. After incubation with DOPA (0 to 750µM) for 24 hours levels of 
DOPA in hydrolysed cell proteins was measured by HPLC (expressed as mMoles of DOPA 
per Mole tyrosine). B. The effect of DOPA on viability of young (PD16) and aging (PD36) 
cells was measured by quantifying LDH release from cells after incubation with DOPA for 24 
hours. No decrease in cell viability was detected. 
  
Figure 4: A. The degradation rate of 14C-leucine labelled (bulk) proteins was measured in 
young (PD16) and aging (PD36) MRC-5 cells over an 8 hour period. This was expressed as a 
percentage of the total pool of 14C-leucine labelled proteins generated in the preceding 24 
hours. B. The degradation of 14C-DOPA labelled (oxidised) proteins was measured in young 
(PD16) and aging (PD36) MRC-5 cells over an 8 hour period. This was expressed as a 
percentage of the total pool of 14C-DOPA labelled proteins generated in the preceding 24 
hours, * p < 0.05, **p < 0.01 and errors represent SEM.  
 
Figure 5: Densitometric analysis of western blots of HSP70 protein levels in aging MRC-5 
cells (PD36) exposed to DOPA (500µM) in tyrosine-depleted EMEM for 24 hours (Dark 
bars) compared to MRC-5 cells incubated in tyrosine-depleted EMEM for 24 hours without 
DOPA (Light bars). Relative expression of HSP27, HSP70 and HSP90 were measured by 
western blot and quantified by densitometry. Data are expressed relative to HSP protein levels 




Figure 6: A. Western blotting analysis of HSP70 protein levels in aging MRC-5 cells (PD36) 
exposed to mild heat stress (42˚C for 15 mins). B. MRC-5 cells (PD36) that had been 
pre-exposed to mild heat stress (labelled as mild stress) or control cells that were not exposed 
to mild heat stress (labelled control) were incubated with 14C-DOPA (5 µM) and increasing 
concentrations of non-labelled DOPA to give final concentrations 50 to 750 µM as indicated. 
The degradation rate of 14C-DOPA-labelled proteins was then measured over the following 8 
hours in tyrosine saturated EMEM. Results represent triplicate sets of cultures ***p < 0.001 






[1] P.A. Szweda, B. Friguet, L.I. Szweda, Proteolysis, free radicals, and aging, Free Radic 
Biol Med, 33 (2002) 29-36. 
[2] G. Carrard, A.L. Bulteau, I. Petropoulos, B. Friguet, Impairment of proteasome structure 
and function in aging, Int J Biochem Cell Biol, 34 (2002) 1461-1474. 
[3] A. Stolzing, T. Grune, The proteasome and its function in the ageing process, Clin Exp 
Dermatol, 26 (2001) 566-572. 
[4] W.F. Ward, Protein degradation in the aging organism, Prog Mol Subcell Biol, 29 (2002) 
35-42. 
[5] M. Gaczynska, P.A. Osmulski, W.F. Ward, Caretaker or undertaker? The role of the 
proteasome in aging, Mech Ageing Dev, 122 (2001) 235-254. 
[6] A.L. Bulteau, L.I. Szweda, B. Friguet, Age-dependent declines in proteasome activity in 
the heart, Arch Biochem Biophys, 397 (2002) 298-304. 
[7] A.M. Cuervo, J.F. Dice, When lysosomes get old, Exp Gerontol, 35 (2000) 119-131. 
[8] M. Martinez-Vicente, G. Sovak, A.M. Cuervo, Protein degradation and aging, Exp 
Gerontol, 40 (2005) 622-633. 
[9] R.T. Dean, R. Dunlop, P. Hume, K.J. Rodgers, Proteolytic 'defences' and the accumulation 
of oxidized polypeptides in cataractogenesis and atherogenesis, Biochem Soc Symp, (2003) 
135-146. 
[10] R.A. Dunlop, K.J. Rodgers, R.T. Dean, Recent developments in the intracellular 
degradation of oxidized proteins, Free Radic Biol Med, 33 (2002) 894-906. 
[11] M. Le Pecheur, E. Bourdon, E. Paly, L. Farout, B. Friguet, J. London, Oxidized SOD1 
alters proteasome activities in vitro and in the cortex of SOD1 overexpressing mice, FEBS 
Lett, 579 (2005) 3613-3618. 
[12] N. Sitte, K. Merker, T. von Zglinicki, T. Grune, Protein oxidation and degradation during 
proliferative senescence of human MRC-5 fibroblasts, Free Radic Biol Med, 28 (2000) 
701-708. 
[13] H.A. Headlam, M. Gracanin, K.J. Rodgers, M.J. Davies, Inhibition of cathepsins and 
related proteases by amino acid, peptide, and protein hydroperoxides, Free Radic Biol Med, 
40 (2006) 1539-1548. 
[14] J.F. Dice, Chaperone-mediated autophagy, Autophagy, 3 (2007) 295-299. 
[15] J. Imai, M. Maruya, H. Yashiroda, I. Yahara, K. Tanaka, The molecular chaperone 
Hsp90 plays a role in the assembly and maintenance of the 26S proteasome, Embo J, 22 
(2003) 3557-3567. 
[16] J.R. Glover, S. Lindquist, Hsp104, Hsp70, and Hsp40: a novel chaperone system that 
rescues previously aggregated proteins, Cell, 94 (1998) 73-82. 
[17] A.Y. Liu, Y.K. Lee, D. Manalo, L.E. Huang, Attenuated heat shock transcriptional 
response in aging: molecular mechanism and implication in the biology of aging, Exs, 77 
(1996) 393-408. 
[18] K.J. Rodgers, J.L. Ford, U.T. Brunk, Heat shock proteins: keys to healthy ageing?, 
Redox Rep, 14 (2009) 147-153. 
[19] S. Fu, M.J. Davies, R. Stocker, R.T. Dean, Evidence for roles of radicals in protein 
oxidation in advanced human atherosclerotic plaque, Biochemical Journal, 333 (1998) 
519-525. 
[20] S. Fu, R. Dean, M. Southan, R. Truscott, The hydroxyl radical in lens nuclear 
cataractogenesis, Journal of Biological Chemistry, 273 (1998) 28603-28609. 
[21] K.J. Rodgers, H. Wang, S. Fu, R.T. Dean, Biosynthetic incorporation of oxidized amino 
acids into proteins and their cellular proteolysis, Free Radic Biol Med, 32 (2002) 766-775. 
 26 
[22] K.J. Rodgers, P.M. Hume, R.A. Dunlop, R.T. Dean, Biosynthesis and turnover of 
DOPA-containing proteins by human cells, Free Radic Biol Med, 37 (2004) 1756-1764. 
[23] K. Ozawa, M.J. Headlam, D. Mouradov, S.J. Watt, J.L. Beck, K.J. Rodgers, R.T. Dean, 
T. Huber, G. Otting, N.E. Dixon, Translational incorporation of 
L-3,4-dihydroxyphenylalanine into proteins, Febs J, 272 (2005) 3162-3171. 
[24] A. Miserez, T. Schneberk, C. Sun, F.W. Zok, J.H. Waite, The transition from stiff to 
compliant materials in squid beaks, Science, 319 (2008) 1816-1819. 
[25] S. Ito, K. Jimbow, T. Kato, M. Kiyota, K. Fujita, Protein-bound dopa and 
5-S-cysteinyldopa in non-melanogenic tissues, Acta. Derm. Venereol., 63 (1983) 463-467. 
[26] S.P. Gieseg, J.A. Simpson, T.S. Charlton, M.W. Duncan, R.T. Dean, Protein-bound 
3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to 
proteins, Biochemistry, 32 (1993) 4780-4786. 
[27] K.J. Rodgers, R.T. Dean, Assessment of proteasome activity in cell lysates and tissue 
homogenates using peptide substrates, Int J Biochem Cell Biol, 35 (2003) 716-727. 
[28] R.P. Orange, E.G. Moore, Functional characterization of rat mast cell arylsulfatase 
activity, J Immunol, 117 (1976) 2191-2196. 
[29] J. Liu, G.K. Sukhova, J.T. Yang, J. Sun, L. Ma, A. Ren, W.H. Xu, H. Fu, G.M. Dolganov, 
C. Hu, P. Libby, G.P. Shi, Cathepsin L expression and regulation in human abdominal aortic 
aneurysm, atherosclerosis, and vascular cells, Atherosclerosis, 184 (2006) 302-311. 
[30] S. Fu, M.-X. Fu, J.W. Baynes, S.R. Thorpe, R.T. Dean, Presence of dopa and amino acid 
hydroperoxides in proteins modified with advanced glycation end products : amino acid 




Marked version: major changes are shown in blue text. Please note the manuscript has been 
re-structured and the results and discussion has been more clearly demarcated. 
USING AN IN VITRO MODEL TO STUDY OXIDISED PROTEIN ACCUMULATION IN 
AGEING FIBROBLASTS 
 
Nae Shiozawa-West, Rachael A. Dunlop and Kenneth J. Rodgers 
 
The Cell Biology Group, School of Life Sciences, University of Technology Sydney, Ultimo, 
NSW, 2007, Australia 
Address correspondence to: Associate Professor Kenneth J. Rodgers, School of Life Sciences, 
University of Technology Sydney, Faculty of Science, Building 4, Level 7, Thomas Street, 
Ultimo, NSW, 2007, Australia. 
Email: Kenneth.rodgers@uts.edu.au 
 
Running title: DOPA in ageing cells   
*REVISED Manuscript (text with changes Marked)
Click here to view linked References
 2 
ABSTRACT  
Background: The accumulation of oxidised proteins in ageing cells and tissues results from an 
increase in oxidant damage coupled with impaired degradation of the damaged proteins. Heat 
Shock Proteins (HSP) and other chaperones are required to recognise damaged proteins and 
transport them to the lysosomal and proteasomal degradation pathways. How these systems 
fail in ageing cells is not clear. 
Methods: We monitor oxidised protein accumulation, the activity of the proteasome and 
lysosomal proteases, and HSP levels in MRC-5 fibroblasts throughout their mitotic lifespan. 
We then use a novel in vitro cell culture model to experimentally generate oxidised proteins 
in young and old MRC-5 fibroblasts and compare their rates of degradation and changes in 
the key pathways involved in oxidised protein removal.  
Results: We show that the activity of the proteasome and some lysosomal enzymes decreases 
with ageing in MRC-5 cells as do levels of HSP70 but this is not associated with an 
accumulation of oxidised proteins which only occurs as cells closely approach post-mitotic 
senescence. Old cells are unable to degrade experimentally generated oxidised proteins as 
efficiently as young cells. Exposure to mild heat stress however increases the efficiency of 
oxidised protein degradation by young cells and increases levels of HSP70. 
Conclusions: Our results highlight the importance of the HSP/chaperone system in oxidised 
protein metabolism, particularly in aging cells.  
General significance: These data might have implications for the development of therapies for 
pathologies associated with protein accumulation and suggest that the HSP/chaperone system 
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The accumulation of oxidised proteins and a gradual decline in proteasome [1-4] and 
lysosome function [5-8] are features of cellular aging. The accumulation of oxidised proteins 
results from an increase in oxidant damage coupled with the less efficient removal of the 
damaged proteins [9]. Removal by proteolysis is the primary defence against the 
accumulation of oxidised proteins [10]. Protein oxidation can result in protein unfolding 
which can expose previously buried hydrophobic regions and, if not rapidly recognised by 
heat shock proteins (HSPs), unfolded proteins can form aggregates through hydrophobic 
interactions [10]. Once this process is initiated, aggregates can grow and be stabilised by 
covalent cross-links, eventually rendering them protease-resistant. Failure of HSPs to rapidly 
recognise, bind to, and transport oxidised proteins to the degradation machinery can 
potentially result in protein aggregation and accumulation even when the proteolytic 
machinery is fully active. Since oxidised and aggregated proteins can directly inhibit the 
proteasome [11,12] and lysosomal cathepsins [13] it is difficult to determine to what extent 
loss of proteolytic activity in ageing is due to inhibition from accumulating oxidised and 
aggregated proteins. Impairment in the activity of the degradation pathways might not, by 
itself therefore, account for the extent of oxidised protein accumulation reported in aging. 
HSPs and other chaperones are required to recognise and target damaged proteins to both the 
lysosomal [14] and proteasomal pathways [15,16], failure of this quality control system to 
rapidly bind damaged proteins increases the likelihood of protein aggregation, cross-linking 
and resistance to proteolysis. Attenuated induction of HSP expression has been associated 
with fibroblast aging in vitro and with the age of primary cells obtained from donors [17,18]  
Naturally ageing human diploid fibroblast cells eventually reach their post-mitotic, 
Hayflick limit of replicative capacity and enter irreversible growth arrest or senescence. In the 
present studies we monitor oxidised protein levels in aging MRC-5 cells and correlate this 
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with changes in proteolytic activity and levels of HSPs. To generate ‘oxidised proteins’ in 
cells we use a model we have developed that allows cells to biosynthetically incorporate 
L-3,4-dihydroxyphenylalanine (DOPA) into proteins. DOPA is the primary oxidation product 
of hydroxyl radical attack on tyrosine residues and is present in proteins in tissues from 
age-related diseases such as atherosclerosis [19] and cataractogenesis [20]. We have 
previously demonstrated that DOPA can be mistakenly incorporated into cell proteins during 
protein synthesis and replaces the protein amino acid L-tyrosine [21,22]. Incorporation of 
DOPA into proteins can lead to protein misfolding and exposure of previously buried 
hydrophobic regions resulting in loss of solubility [23]. DOPA is also a potent cross-linker 
and can form cross-links with histidine residues [24] and cysteine residues [25]. This provides 
a useful in vitro model to study protein misfolding and aggregation. We use this model system 
to examine the effects of DOPA-containing proteins, on the protein degradation pathways in 
young and old fibroblasts. We investigate how HSP levels change with ageing and 
demonstrate that mild heat stress can reduce the accumulation of oxidised proteins in this 
model.  
 
2. Material and methods 
2.1 Reagents 
 
EMEM (Eagle’s Minimal Essential Medium) deficient in tyrosine, phenylalanine and Phenol 
Red was from JRH Biosciences. L-[3-14 C-alanine] dopa and L-[U-14 C] leucine were !from 
Amersham Biosciences (GE Healthcare). N-succinyl-Leu-Leu-Val-Tyr-AMC (where Suc is 
succinyl and AMC is 7-amino-4-methylcoumarin) and Boc-Leu-Ser-Thr-Arg-AMC (where 
Boc is t-butoxycarbonyl) were purchased from Sigma Chemical Co. Z-Arg-Arg-AMC (where 
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Z is benzyloxycarbonyl), Z-Phe-Arg-AMC and Ac-Nle-Pro-Nle-Asp-AMC (where Ac is 
acetyl and Nle is norleucine) were from Bachem AG. Anti-Hsp70 (cat # 386013) and 
anti-Hsp27 rabbit polyclonal (cat # 386035) were purchased from Calbiochem, Darmstadt, 
Germany. Anti-Hsp90 rabbit polyclonal (cat# ab53110) and HRP-conjugated anti-rabbit IgG 
H&L goat polyclonal secondary antibody (cat# ab6721) was purchased from Abcam Inc, 
Cambridge, UK.  
All aqueous solutions and buffers were prepared using water filtered through a 
four-stage Milli-Q system (Millipore). All other chemicals, solvents and chromatographic 
materials were of analytical reagent or cell-culture grade. 
 
2.2 Cell culture 
 
MRC-5 cells, a human lung fibroblast cell line (ATCC® number, CCL-171) were cultured in 
EMEM supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS), 100 U/mL 
penicillin and 0.1 mg/mL streptomycin (concentrated premix; Cambrex Bio Science; MD, 
USA) and 2 mM L-glutamine. Cells were maintained at 37°C with 5% CO2.  
For studies involving the synthesis of DOPA-containing proteins, cells were cultured in 
tyrosine-deficient EMEM supplemented with a range of concentrations (50–750 µM) of 
L-DOPA over 4–24 hours. As negative controls, cells were incubated in tyrosine- deficient 
EMEM. Medium also contained 10% heat-inactivated FBS, 100 U/mL penicillin and 0.1 
mg/mL streptomycin (premixed) and 2 mM L-glutamate.. After incubations, medium was 
removed and the MRC-5 cells harvested by trypsin-EDTA. Cell pellets were then collected by 
centrifugation at 2,500 rpm for 5 min, washed twice with phosphate buffered saline (PBS) and 
stored at -80  ̊C until required. The extent of DOPA incorporation into cellular proteins is 
expressed as a ratio mole per mole of tyrosine. 
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The cells subjected to mild heat stress were placed at 45°C for 15 minutes in atmospheric CO2 
prior to treatment with DOPA. 
 
2.3 HPLC analysis 
 
Cell were washed and lysed by three freeze thaw cycles. Proteins were isolated by 
precipitation in TCA (5%), delipidated and washed by resuspending twice in 5% TCA 
containing 0.02% sodium deoxycholate and 0.15 mg/mL sodium borohydride (reducing 
agent) then washed twice with ice-cold acetone. The protein pellets were hydrolysed under 
anaerobic conditions (HCl and β-mercaptoacetic acid) using a standard gas-phase 
acid-catalysed method [26]. The level of DOPA in protein was determined by reverse-phase 
HPLC, using a LC-10A system from Shimadzu Co. (Kyoto, Japan) equipped with a 
CTO-10ASvp column oven (Millipore Co.) set at 30°C and methods described previously 
[19,21]. System operation was automated by Class LC-10 software. Chomatography was 
performed on a Zorbax ODS column with an attached Pelliguard guard column (LC-18). The 
elution was performed using a binary gradient of Buffer A (100 mM sodium perchlorate and 
10 mM sodium phosphate buffer, pH 2.5) and Buffer B (80% (v/v) methanol) at a flow rate of 
1 mL/min as follows: isocratic elution with 4% Buffer B for 25 min, 10% Buffer B for 5 min, 
increase to 40% Buffer B and maintained 40% Buffer B for 20 min, re-equilibration at 1% 
Buffer B for the final 10 min. UV λ280 nm (Shimadzu Co.), fluorescence (λex280nm and λem 
320nm, Hitachi F-1080, Tokyo, Japan) and electrochemical detector (ECD; Antec Leyden 
BV, Zoeterwoude, Netherlands) with the electrode potential set at 1.2 V measurements of the 
eluent were monitored in series. The amount of oxidised derivative incorporated into proteins 
was quantified from standards used, calculated as a ratio of mol oxidised derivative to mol of 
parent amino acid tyrosine.  
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2.4 Activity studies 
 
All assays were carried out in 96-well plates in triplicates and no protein control was included. 
Change in fluorescent or colourimetric unit/min/protein (g) was calculated and expressed as a 
percentage (%) of control values. The protein concentration was determined using the 
Bradford-based total protein assay. 
 
2.5 Measurement of proteasome activity  
 
Proteasome chymotryptic, peptidylglutamyl-peptide-hydrolysing (PGPH) and tryptic 
activities were measured by the initial linear rates of cleavage of the fluorescent reporter 
group (7-amino-4-methylcoumarin/AMC) from peptide substrates 
N-Succinyl-Leu-Leu-Val-Tyr-AMC (Sigma-Aldrich Co., MO, USA), 
Acetyl-Nle-Pro-N[27]le-Asp-AMC (where Nle is norleucine; Bachem Holding AG, 
Bubendorf, Switzerland), Boc-Leu-Ser-Thr-Arg-AMC (where Boc is t-butoxycarbonyl; 
Sigma-Aldrich Co.) respectively (previously described in [22,27]. Pelleted cells were 
resuspended in homogenising buffer containing 250 mM sucrose, 5 mM MgCl2, 2 mM ATP, 
1 mM DTT, 0.025% digitonin, 0.5 mM EDTA and 50 mM Tris-HCl, pH 7.5 at 4°C. This 
homogenate was incubated on ice for 5 min to allow digitonin-mediated permeabilisation of 
the cell membrane followed by centrifugation at 20,000 x g for 15 min at 4°C. Samples were 
incubated for 30 min at room temperature in the presence or absence of the proteasome 
inhibitor epoxomicin (20 µM). Proteasome activity was measured in reaction buffer (0.05 
mg/mL BSA, 40 mM KCl, 5 mM MgCl2, 0.5 mM ATP, 1 mM DTT and 50 mM Tris-HCl, 
pH7.5) with 100 µM chymotryptic/PGPH or 600 µM for the tryptic substrates by measuring 
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the change in fluorescence (λex360 nm and λem469 nm) for 30 min.  
 
2.6 Measurement of cathepsin L, B and S activities 
 
Cathepsin L, B and S activity were measured by the initial linear increase in fluorescence 
following the cleavage of AMC from peptide substrates Z-Phe-Arg-AMC (where Z is 
benzyloxycarbonyl), Z-Arg-Arg-AMC and Z-Val-Val-Arg-AMC (all from Bachem Holding 
AG) respectively [22]. For cathepsins L and B, 1/21 of final volume of cell lysate and reaction 
buffer (2.5 mM DTT, 5 mM EDTA, 1 µM pepstatin A, 5 mM benzamidine, 0.1 M phosphate 
buffer pH 6 (cathepsin B) or pH 5.5 (cathepsin L) containing 0.005% Brij 35) were incubated 
for 5 min at room temperature on a shaker. 200 µM cathepsin B or L substrate was added to a 
final volume of 210 µL per assay and the fluorescence was measured (λex360 nm and λem469 
nm) for 30 min. For cathepsin S, different reaction buffer was used (5 mM benzamidine, 5 
mM EDTA, 1 µM pepstatin A, 0.01% Triton X-100, 1 mM PMSF, 5 mM DTT and 0.2 M 
phosphate buffer, pH 7.5) and was incubated for 60 min at 40°C and the fluorescence was 
measured for 50 min.  
 
2.7 Measurement of arylsulphatase activity 
 
Arylsulphatase activity was measured by hydrolysis of the ester sulphate bond of the 
fluorogenic substrate, p-nitrocatecholsulphate [28]. 19x volume of reaction buffer (0.1% 
Triton X-100, 7.5 mM p-nitrocatecholsulphate and 0.1 M sodium acetate buffer, pH 5.0) was 
added to cell lysate and incubated at 37°C for 30 min. The reaction was terminated with the 
addition of an equal amount of stop buffer (4.76 mM HCl containing 0.19% (w/v) 
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hydroquinone freshly mixed 1:1 with 2.38 M NaOH containing 4.76% Na2SO3). Absorbance 
was measured at λ540 nm. 
 
2.8 Measurement of acid phosphatase activity 
 
Acid phosphatase activity was measured in cell lysates by hydrolysis of the phosphate group 
from the fluorogenic substrate, p-nitrophenyl phosphate. 4x volume of reaction buffer (8 mM 
p-nitrophenyl phosphate, 90 mM sodium acetate-acetic acid, pH 5.0) was added to each well 
then the plate incubated at 37°C for 30 min. The reaction was terminated by the addition of 
NaOH stop buffer to a final concentration of 176 mM NaOH. Absorbance was measured at 
λ410 nm.  
  
2.9 Measurement of lysosomal acid lipase activity 
 
Lysosomal acid lipase activity was estimated in the cell lysates by hydrolysis of the 
fluorogenic substrate, 4-methylumbelliferyl-oleate [29]. Initially, 4-methylumbelliferyl-oleate 
is resuspended in hexane (100 mg/mL) and then diluted 1 in 100 in 4% Triton X-100. 2x the 
volume of 4-methylumbelliferyl-oleate stock and 5x volume of assay buffer (0.2 M sodium 
acetate and 0.001% Tween 20, pH 5.5) were added to samples and incubated at 37°C for 30 
min; the reaction was stopped by adding a half volume of 0.75 M Tris, pH 8.0. Fluorescence 
measurements were measured with λex360 nm and λem469 nm. 
 
2.10 Degradation studies 
 
The rate of degradation of bulk proteins containing L-[U-14C]leucine (14C-leucine) or 
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L-3,4-dihydrophenyl[3-14C]alanine (14C-DOPA), synthesised in the presence of DOPA was 
measured. The specific activities of 14C-leucine and 14C-DOPA were 51.0 mCi/mmol and 306 
mCi/mmol respectively, and the radioactive concentrations were 51.0 µCi/mmol and 250 
µCi/mmol, respectively. Both radioactive labels were purchased from GE Healthcare. The cell 
culture method used to generate DOPA-containing proteins was as described previously [21]. 
Cells maintained in tyrosine- and leucine-free EMEM were incubated in the presence 
of 0.25 µM 14C-leucine and varying concentrations of DOPA (0, 250, 500, 750 µM) for 24 h. 
After 24 h of incubation, the medium was replaced with ‘chase’ medium; EMEM saturated 
with 10 µM leucine and 10 µM tyrosine, and cells were maintained in culture for a further 8 h 
to allow degradation of the labelled proteins. In experiments using 14C-DOPA, tyrosine-free 
EMEM contained 5 µM 14C-DOPA (with the balance of unlabelled DOPA) and EMEM 
saturated with 10 µM tyrosine was used as the ‘chase’ medium. Cells were harvested and the 
radioactivity in the culture medium and cell lysate measured by liquid scintillation counting. 
Bulk (14C-leucine-labelled) and 14C-DOPA-containing protein degradation was measured 
from the release of free radioactivity into the culture medium. Degradation was expressed as a 
percentage of the free radioactivity counts in medium to the total number of counts in the 
system (ie the total pool of labelled proteins at the start of the degradation period). 
 
2.11 Fluorescence microscopy 
 
Cellular autofluorescence was imaged using an Olympus IX71 Inverted Research 
Fluorescence Microscope (Olympus Co., Tokyo, Japan) equipped with an NIBA filter unit 
(λex470–490 nm, λem515–550 nm). Cells were exposed for 0.22 s. and images captured using 
the DP Controller software version 3.1.1.267 (Olympus Co.). 
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2.12 Western blotting 
 
The SDS-polyacrylamide gel electrophoresis method described here was modified from the 
manufacturer’s instructions for NuPAGE® Novex Bis-Tris gels (Invitrogen Co.). Cell pellets 
were lysed using the a Mammalian Cell Lysis kit (Sigma-Aldrich). Cell lysates were mixed 
with 4x NuPAGE® LDS sample buffer and 10x NuPAGE® reducing agent, denatured at 
100°C for 5 min and immediately cooled on ice for 2 min. Samples containing up to 20 µg of 
protein were loaded per lane alongside 10 µL SeeBlue Plus 2 Pre-Stained molecular weight 
markers (4–250 kDa) onto a 10-well NuPAGE® Bis-Tris 4–12% pre-cast gel, 1.5 mm thick. 
The proteins were separated under denaturing conditions in NuPAGE® MES SDS Running 
Buffer, pH 6.4 with an addition of 500 µL NuPAGE® antioxidant to maintain reducing 
conditions. The electrophoresis was run at 100 V for 5 min, 150 V for 5 min followed by 200 
V for 30 min for MES using the XCell SureLockTM Mini-Cell system (Invtirogen Co.). 
After SDS-PAGE separation, proteins were transferred onto nitrocellulose membranes, using 
the iBlotTM dry blotting system (Invitrogen Co.) and iBlotTM transfer stacks over 7 min using 
built-in ‘P2’ transfer program. Nitrocellulose membranes were blocked by incubating in 5% 
skim milk in Tris-buffered saline (10 mM Tris-HCl, pH 7.4, 150 mM NaCl) overnight at 4°C 
and incubated with the primary antibody diluted in 0.1% TBS-T (10 mM Tris-HCl, pH 7.4, 
150 mM NaCl and 0.1% Tween 20) for 1 h at room temperature: rabbit polyclonal 
anti-HSP27 (Calbiochem #386013) was used at 1:10,000, rabbit polyclonal anti-HSP70 
(Calbiochem #386035) was used as 1:50,000 and rabbit polyclonal anti-HSP90 (Abcam Inc. 
#ab53110) was used as 1:1,000. 
Membranes were washed and incubated in secondary antibody conjugated to HRP 
diluted in 0.1% TBS-T for 1 h at room temperature on a rotating platform. HRP-conjugated 
anti-rabbit IgG H&L goat polyclonal secondary antibody from Abcam Inc. (cat. no. #ab6721) 
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at 1:10,000 and the membrane was incubated in HRP-ECL Western Blotting detecting 
solution as per manufacture’s instructions (GE Healthcare) at room temperature for a 
maximum of 5 min. The detection reagent was removed and the membrane was exposed 
under chemiluminescence on the ChemiDoc XRS system (Bio-Rad Laboratories, Inc.). The 
relative expression of target protein was analysed using the densitometry function of 
QuantityOneTM software version 4.6.  
 
2.13 Statistical Analysis 
 
All results presented here as mean plus or minus standard error of the mean ( ±SEM). 
Statistical analyses were evaluated using GraphPad software (CA, USA) Prism 4 version 4.03 
either using a one-way or a two-way ANOVA with Bonferroni multiple comparison post-tests 
to compare replicate means between different treatments across the samples. Differences were 




3.1 DOPA-containing proteins accumulate with in vitro cellular aging.  
 
MRC-5 fibroblasts are capable of 42 to 46 population doublings before the onset of 
post-mitotic senescence. MRC-5 cells were initiated in culture at population doubling (PD) 10 
and maintained until senescence was reached (approximately 6 months in culture). Cells were 
sampled at various PD times (203 separate lysates) and protein-bound DOPA quantitated as a 
measure of oxidative damage to proteins. DOPA was released from the protein chain by acid 
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hydrolysis [19] and levels quantitated using HPLC. DOPA levels (µmol DOPA per mol 
tyrosine) remained constant until cells entered the final phases of their mitotic life and a steep 
increase in DOPA levels in proteins was evident (Figure 1A: PD38: P < 0.001). This linear 
increase continued until cells entered post-mitotic senescence and did not undergo further 
division (PD42; P < 0.001, Figure 1A).  
Post-mitotic cells were then maintained in culture for 3 months after becoming senescent. 
When viewed with microscopy, intense perinuclear fluorescence was present, consistent with 
the presence of protein aggregates (Figure 1B). This was not seen in young (PD16) or aging 
(PD36) cells (data not shown).  
 
3.2 Changes in HSP levels and proteasomal and lysosomal activity with aging.  
 
There was an overall attenuation of proteasomal catalytic activities in aging cells (PD36) 
when compared to young cells (PD16). The tryptic activity was the most significantly affected, 
falling to 43% (P = 0.0360), followed by the PGPH activity which was 66% (P = 0.0022) of 
that in young cells (Table 1). There was a trend towards reduced activity at the chymotryptic 
site (10% reduction in aging cells) but this did not reach significance (Table 1). Lysosomal 
protease and non-protease activities were also attenuated, reflecting a general decline in 
lysosomal function (to ~70%) in aging cells (Table 1).   
Heat shock proteins have also been reported to decline with age, and we used western blotting 
to quantitate the levels of HSP27, HSP70 and HSP90 in cell lysates. Levels of HSP27 and 
HSP90 protein did not change with aging in MRC-5 fibroblasts (Figure 2B and C), however 
HSP70 protein levels were significantly (P < 0.001) decreased (Figure 2A).  
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3.3 Generating DOPA-containing proteins in cells: a model for oxidized protein 
accumulation 
 
We experimentally generated DOPA-containing proteins in young (PD16) and aging (PD36) 
cells using a novel model developed in our laboratory [16,25]. In tyrosine-free medium the 
young rapidly dividing cells readily incorporated DOPA into newly synthesised proteins 
(Figure 3A) and even at 50 µM DOPA around 23% of tyrosine residues had been replaced 
with DOPA (Figure 3A). In older cells the rate of cell division and protein synthesis are much 
slower and the level of DOPA incorporation increased with increasing supply of DOPA in the 
medium (Figure 3A) and at 750µM DOPA around 9% of tyrosine residues had been replaced 
with DOPA (Figure 3A).  
 
3.4 Biosynthetically generated DOPA-containing proteins did not decrease cell viability 
 
To ensure the presence of DOPA-containing proteins did not adversely affect cell viability, 
we conducted LDH assays on young and aging cells. There was no increase in LDH release 
after 24 hours by young or aging cells when incubated with 750 µM DOPA or below (Figure 
3B).  
 
3.5 Turnover of bulk proteins and DOPA-containing proteins in young and ageing cells  
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To determine the effects of aging on the turnover of normal and DOPA-containing proteins, 
young (PD16) and aging (PD36) cells were incubated with increasing concentrations of 
DOPA, and the degradation of bulk cell proteins (14C-leucine-labeled) and 
‘oxidized/damaged’ proteins (14C-DOPA-labeled proteins) measured. After a 24 hr protein 
labeling period, cells were subjected to a “chase period” consisting of an 8 hour incubation in 
medium containing tyrosine and lysine (25 mM) to allow the degradation of labelled proteins. 
Release of the radiolabeled amino acid was quantitated as described previously [25].  
The degradation of bulk proteins (labeled with 14C-leucine) by aging cells (PD36) was 
significantly impaired at the highest concentration of DOPA (750 µM), when compared to 
young cells (PD16) (Figure 4A). This suggests that the aging cells were unable to maintain 
basal protein degradation rates when DOPA-containing proteins were present at higher levels. 
We then selectively examined the turnover of oxidised proteins, (labeled with 14C-DOPA) 
over the 8 hour chase period. The rate of removal of DOPA-containing proteins was 
significantly faster (~4 times) than bulk proteins (Figure 4B). Indicating that the proteolytic 
machinery of the cell specifically recognised DOPA-containing proteins as substrates for 
degradation. The rate of turnover of DOPA-containing proteins in aging cells however 
declined with increasing concentrations of DOPA to a greater extent than in young cells 
which were only able to maintain the higher level of turnover at concentrations up to 500 µM 
DOPA (Figure 4B).  
 
3.6 DOPA-containing proteins restored HSP70 levels in ageing cells 
  
In ageing cells levels of HSP70 protein had significantly declined by PD30 (Figure 2A). 
Treatment of PD36 cells with DOPA (500µg for 24 hours) had no effect on HSP levels in 
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young cells but selectively increased HSP70 levels in old cells effectively restored it to the 
level present in young cells (Figure 5).  
 
3.7 Mild heat stress improves the rate of turnover of DOPA-containing proteins 
 
We exposed old cells to mild heat stress by incubating them at 45°C for 15 min immediately 
prior to incubation with DOPA (0 – 24 hrs). We then compared the turnover of 
DOPA-containing proteins in aging cells that had been subjected to mild heat stress to control 
cells (without mild heat stress) and found there was a significant increase in the rate of 
degradation of DOPA-containing proteins at 750 µM in the heat stressed cells (Figure 6B).  
There was a marked increase in the expression of HSP70 by western blot after exposure to 
mild heat stress (Figure 6A) demonstrating that this was one factor that contributed to their 






One of the most commonly observed changes in aging is the accumulation of damaged and 
aggregated material (lipofuscin/age-pigments) in cells, a large proportion of which is oxidised 
protein. The primary pathway for removal of oxidised proteins is degradation to their 
constituent amino acids, but this process appears to be impaired with aging and in some 
age-related diseases [30]. In the present studies we used an in vitro model system to examine 
the factors contributing to the decreased ability of ageing MRC-5 fibroblasts to degrade 
experimentally generated oxidised and aggregate-prone proteins.  
Using protein-bound DOPA as a marker of oxidative damage to proteins, we monitored 
oxidised protein accumulation throughout the lifespan of MRC-5 cells. There was no increase 
in DOPA-containing proteins throughout most of the ageing process but a rapid increase in 
DOPA was evident in proteins when cells reached PD36 and the rate of cell division was 
greatly reduced. This is consistent with the idea that the distribution of oxidised proteins 
amongst daughter cells is an important mechanism for reducing oxidised protein 
accumulation in dividing cells. DOPA levels increased further as the cells entered 
post-mitotic senescence (PD42) (Figure 1A). The accumulation of DOPA-containing proteins 
corresponded to a decline in the activity of the proteasome and some lysosomal enzymes 
(Table 1) and a decline in levels of HSP70. Even although a significant decline in HSP70 
protein levels were observed at PD32, levels of HSP27 and HSP90 were maintained even 
after senescence was reached suggesting that certain HSPs selectively decline with cellular 
aging.  
We then generated DOPA-containing proteins in cells as a model of oxidised proteins. DOPA 
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is known to be the primary oxidation product of tyrosine residues in proteins and is present in 
proteins in ageing [20] and disease [19]. This approach has advantages over conventional 
methods of generating oxidised proteins since the use of strong oxidants such as paraquat [26] 
or hydrogen peroxide [27] can cause extensive damage to other biological molecules such as 
lipids and DNA [1,17]. Using the incorporation approach we can generate a precise pool of 
proteins containing oxidised amino acids without damage to other molecules and can thereby 
preserve cell viability. To do this we supplied DOPA to the cells in tyrosine-free medium so 
that DOPA could more effectively compete with tyrosine (present in the cell and in the foetal 
calf serum) for charging by tyrosyl tRNA synthetase and insertion into the polypeptide chain 
of proteins [16,25]. The presence of DOPA and DOPA-containing proteins had no effect on 
cell viability at the levels we used (Figure 3B). Incorporation of DOPA into proteins results in 
the generation of non-native/oxidised proteins in cells and thus might equate to a period of 
acute oxidative stress or an inflammatory insult in vivo. When DOPA-containing proteins 
were present in cells, both young and aging cells degraded these proteins much more rapidly 
than native (14C leucine labeled) proteins (Figure 4A & B) proving evidence that the cells 
recognise at least some of the DOPA-containing proteins as damaged and selectively 
degraded them. We have previously demonstrated that degradation of DOPA-containing 
proteins by cells is biphasic, and at higher levels of DOPA incorporation, DOPA-containing 
proteins resist degradation [16] and aggregate [6]. In the present studies, at higher DOPA 
concentrations, there was a significant decline in the rate of degradation of DOPA-containing 
proteins in aging cells relative to young cells (Figure 4B). The ability of aging cells to 
degrade aggregate-prone, DOPA-containing proteins was clearly impaired. The two major 
pathways for the degradation of oxidized proteins are the proteasome and lysosomes. We 
showed that there was a reduction in the activity of the proteasome in aging cells compared to 
young cells where the trypsin-like activity was reduced to 43%, the PGPH to 66% and the 
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chymotrypsin to 89% (Table 1). The observation of an age-related reduction in proteolytic 
activity is supported by a large body of evidence [2,30] and this also applies in age-related 
pathologies [31–35]. A reduction in proteasome activity in aging cells also corresponded to a 
decline in the activity of the lysosomal enzymes; aryl sulphatase, acid phosphatase and acid 
lipase (Table 1). This may have been a result of an overall reduction in the population of 
lysosomes in the ageing cells.  
There was a significant reduction in HSP70 protein levels in aging MRC-5 cells before there 
was any evidence of oxidised protein accumulation (Figure 2A). HSP70 is an inducible 
cytosolic heat shock protein that rapidly responds to thermal or oxidative stress, to sequester 
misfolded proteins by its binding domain, and thus preventing damaged proteins from 
forming aggregates. In this study we showed that HSP70 could be induced in aging cells both 
by exposure to DOPA or mild heat stress (Figures 5 and 6). Exposure to mild heat stress 
resulted in a small but significant increase in the rate of degradation of DOPA-containing 
proteins suggesting that HSP70 played a role in facilitating the degradation of these proteins 
(Figure 6B). 
The accumulation of oxidised proteins in cells and tissues is a common feature of 
neurodegeneration and other disorders associated with aging. As was evident in the present 
studies, cell division and the distribution of oxidised material amongst daughter cells is an 
important mechanism that allows dividing cells to limit the accumulation of oxidised proteins 
[36,37]. The inability of senescent cells to divide could therefore account for the rapid 
accumulation of DOPA-containing proteins. This could occur in long-lived cells such as 
retinal pigment epithelial cells or neurons. Age pigments have also been shown to directly 
inhibit the function of the proteasomes and the lysosomes leading to a decline in cell function.  
Whilst a great deal of research has focused on changes to the proteolytic machinery in aging 
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and neurodegeneration HSPs, which serve a critical upstream function, have received less 
attention. HSPs serve several roles in maintaining homeostasis including, protecting against 
aggregation, solubilizing of early stage protein aggregates, assisting in folding of nascent 
proteins or in refolding of damaged proteins. Importantly they also target damaged proteins to 
the degradation machinery and sequester non-degradable proteins to larger aggregates [12].  
 
Conclusions 
By experimentally generating oxidised proteins in cells we showed that the basal turnover of 
cell proteins was maintained in ageing MRC-5 cells and they were able to efficiently degrade 
low levels of oxidised proteins. When higher levels of oxidised proteins were experimentally 
generated however their degradation in ageing cells was less efficient than in young cells. 
Impairment in proteasome activity and a decline in HSP function appeared to contribute to the 
decline in oxidised protein turnover. HSP70 levels were reduced in ageing cells but could be 
increased by mild heat stress resulting in an increased ability to degrade oxidise proteins. 
These studies describe a useful in vitro model to study the mechanisms of degradation of 
damaged or non-native proteins and highlight the importance of heat shock proteins in the 
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Legends to Figures 
 
Table 1: The peptidase activity of the proteasome (chymotrypsin-like, trypsin-like and PGPH 
activities), the lysosomal proteases (cathepsins B, L and S) and activity of lysosomal 
arylsulphatase, acid phosphatase and acid lipase in aging (PD36) MRC-5 cells and young 
(PD16) cells was compared. Activity was measured using fluorescently labelled substrates 
and set at 100% for young cells. Results represent triplicate sets of cultures and data was 
expressed as change in fluorescence per minute per mg of protein. * p < 0.05, **p < 0.01, 
errors represent SEM.  
 
Figure 1: A. Accumulation of protein-bound DOPA in ageing MRC-5 fibroblasts. DOPA in 
hydrolysed cell proteins was measured by HPLC and expressed as a ratio to tyrosine. B. At 
PD42 MRC-5 cells entered post-mitotic senescence. Cells were maintained in culture for 
more than 3 months after reaching post-mitotic senescence and native autofluorescence 
imaged using an inverted Olympus IX71 microscope with a NIBA filter set (ex 470–490nm, 
em 515–550nm) equipped with a DP71 digital camera with exposure of 0.22 seconds.  
 
Figure 2: Densitometric analysis of HSP levels in MRC-5 cell lysates identified by western 
blotting. Cells were examined between PD13 and PD40 for levels of: A. HSP70, B. HSP90 
and C. HSP27. Relative expression was quantified by densitometry (see insets). Statistically 
significant changes in the HSP protein levels relative to the young cells (PD16) were as 
indicated, ** p < 0.01, ***p < 0.001 and errors represent SEM. 
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Figure 3: A. Incorporation of DOPA into cell proteins from young (PD16) and aging (PD36) 
MRC-5 cells was measured. After incubation with DOPA (0 to 750µM) for 24 hours levels of 
DOPA in hydrolysed cell proteins was measured by HPLC (expressed as mMoles of DOPA 
per Mole tyrosine). B. The effect of DOPA on viability of young (PD16) and aging (PD36) 
cells was measured by quantifying LDH release from cells after incubation with DOPA for 24 
hours. No decrease in cell viability was detected. 
  
Figure 4: A. The degradation rate of 14C-leucine labelled (bulk) proteins was measured in 
young (PD16) and aging (PD36) MRC-5 cells over an 8 hour period. This was expressed as a 
percentage of the total pool of 14C-leucine labelled proteins generated in the preceding 24 
hours. B. The degradation of 14C-DOPA labelled (oxidised) proteins was measured in young 
(PD16) and aging (PD36) MRC-5 cells over an 8 hour period. This was expressed as a 
percentage of the total pool of 14C-DOPA labelled proteins generated in the preceding 24 
hours, * p < 0.05, **p < 0.01 and errors represent SEM.  
 
Figure 5: Densitometric analysis of western blots of HSP70 protein levels in aging MRC-5 
cells (PD36) exposed to DOPA (500µM) in tyrosine-depleted EMEM for 24 hours (Dark 
bars) compared to MRC-5 cells incubated in tyrosine-depleted EMEM for 24 hours without 
DOPA (Light bars). Relative expression of HSP27, HSP70 and HSP90 were measured by 
western blot and quantified by densitometry. Data are expressed relative to HSP protein levels 




Figure 6: A. Western blotting analysis of HSP70 protein levels in aging MRC-5 cells (PD36) 
exposed to mild heat stress (42˚C for 15 mins). B. MRC-5 cells (PD36) that had been 
pre-exposed to mild heat stress (labelled as mild stress) or control cells that were not exposed 
to mild heat stress (labelled control) were incubated with 14C-DOPA (5 µM) and increasing 
concentrations of non-labelled DOPA to give final concentrations 50 to 750 µM as indicated. 
The degradation rate of 14C-DOPA-labelled proteins was then measured over the following 8 
hours in tyrosine saturated EMEM. Results represent triplicate sets of cultures ***p < 0.001 
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 Proteasome activity  
 Chymotrypsin-like PGPH Trypsin-like 
Young (PD16) 100 + 5.7 100 + 2.0 100 + 17.2 
Aging (PD36) 88.9 + 0.7 66.1 + 4.4** 42.8 + 6.6* 
    
    
 Lysosomal protease activity  
 Cathepsin L Cathepsin B Cathepsin S 
Young (PD16) 100 + 17.5 100 + 16.6 100 + 30.1 
Aging (PD36) 72 + 8.5 71.1 + 8.17 57.4 + 5.2 
    
    
 Lysosomal enzyme activity  
 Arylsulphatase Acid phosphatase Acid Lipase 
Young (PD16) 100 + 1.4 100 + 0.02 100 + 12.1 
Aging (PD36) 88.2 + 1.7** 83.9 + 0.04** 56.3 + 6.2* 
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